Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Sep;19(9):1274-7.
doi: 10.1023/a:1020338405947.

Predicting the quality of powders for inhalation from surface energy and area

Affiliations

Predicting the quality of powders for inhalation from surface energy and area

David Cline et al. Pharm Res. 2002 Sep.

Abstract

Purpose: To correlate the surface energy of active and carrier components in an aerosol powder to in vitro performance of a passive dry powder inhaler.

Methods: Inverse gas chromatography (IGC) was used to assess the surface energy of active (albuterol and ipratropium bromide) and carrier (lactose monohydrate, trehalose dihydrate and mannitol) components of a dry powder inhaler formulation. Blends (1%w/w) of drug and carrier were prepared and evaluated for dry powder inhaler performance by cascade impaction. The formulations were tested with either of two passive dry powder inhalers, Rotahaler (GlaxoSmithKline) or Handihaler (Boehringer Ingelheim).

Results: In vitro performance of the powder blends was strongly correlated to surface energy interaction between active and carrier components. Plotting fine particle fraction vs. surface energy interaction yielded an R2 value of 0.9283. Increasing surface energy interaction between drug and carrier resulted in greater fine particle fraction of drug.

Conclusions: A convincing relationship, potentially useful for rapid formulation design and screening, was found between the surface energy and area parameters derived from IGC and dry powder inhaler performance.

PubMed Disclaimer

Comment in

References

    1. Int J Pharm. 2001 Apr 17;217(1-2):45-56 - PubMed
    1. Int J Pharm. 1999 Nov 25;191(1):1-14 - PubMed
    1. Pharm Res. 1998 Apr;15(4):562-9 - PubMed
    1. Int J Pharm. 1999 Nov 25;191(1):43-50 - PubMed
    1. Pharm Res. 1999 Feb;16(2):249-54 - PubMed

Publication types

LinkOut - more resources